Business Daily Media

Business Marketing

.

Eisai and Merck Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications

  • Written by ACN Newswire - Press Releases

Eisai and Merck Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications

TOKYO, May 7, 2021 - (JCN Newswire) - Eisai Co., Ltd.and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for applications seeking two new approvals for the combination of LENVIMA, the orally...

Popular

Kleenex Sneesesafe Program Returns to Australian Schools

Sydney, Monday 9th May 2016: Helping school children learn about coughs, colds and flu, and the spread of germs through an interactive respiratory hygiene educational program for teachers of children in the early years of educat...

Trends Brand Marketers Need to Heed - Brand Keys

Marketers cannot use mid-20th century survey tools to measure 21st century consumer values and behaviors because traditional techniques are likely to measure what consumers say, rather than what they think. Today’s consumers simpl...

Validity for Good Ensures Critical Emails Reach Inboxes Amid Ukraine Crisis

Global Email and Success Data Quality Provider Applies Decades of Email Insights to Meet Critical Needs Validity, the leading provider of data quality and email marketing success solutions, recently announced the expansion of...